MDT

86.08

+0.56%↑

A

121.65

+2.99%↑

VEEV

167.9

+0.35%↑

HQY

85.93

+1.81%↑

NEOG

9.5

+2.81%↑

MDT

86.08

+0.56%↑

A

121.65

+2.99%↑

VEEV

167.9

+0.35%↑

HQY

85.93

+1.81%↑

NEOG

9.5

+2.81%↑

MDT

86.08

+0.56%↑

A

121.65

+2.99%↑

VEEV

167.9

+0.35%↑

HQY

85.93

+1.81%↑

NEOG

9.5

+2.81%↑

MDT

86.08

+0.56%↑

A

121.65

+2.99%↑

VEEV

167.9

+0.35%↑

HQY

85.93

+1.81%↑

NEOG

9.5

+2.81%↑

MDT

86.08

+0.56%↑

A

121.65

+2.99%↑

VEEV

167.9

+0.35%↑

HQY

85.93

+1.81%↑

NEOG

9.5

+2.81%↑

Search

Inspire Medical Systems Inc

Închisă

SectorSănătate

57.52 1.84

Rezumat

Modificarea prețului

24h

Curent

Minim

56.35

Maxim

58.11

Indicatori cheie

By Trading Economics

Venit

126M

136M

Vânzări

45M

269M

P/E

Medie Sector

11.231

63.808

Marjă de profit

50.577

Angajați

1,333

EBITDA

33M

50M

Recomandări

By TipRanks

Recomandări

Cumpărare

Prognoză pe 12 luni

+19.98% upside

Dividende

By Dow Jones

Următoarele câștiguri

4 mai 2026

Statistici piață

By TradingEconomics

Capitalizare de piață

-380M

1.6B

Deschiderea anterioară

55.68

Închiderea anterioară

57.52

Sentimentul știrilor

By Acuity

60%

40%

302 / 348 Clasament în Healthcare

Inspire Medical Systems Inc Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

17 apr. 2026, 20:26 UTC

Achiziții, Fuziuni, Preluări

UCB to Buy Neurona Therapeutics for Up to $1.15 Billion

17 apr. 2026, 18:15 UTC

Evenimente importante

Fed's Waller: Prolonged Iran Conflict Could Block Path to Rate Cuts

17 apr. 2026, 16:49 UTC

Evenimente importante

Week Ahead for FX, Bonds: U.S. Retail Sales, PMI -2-

17 apr. 2026, 16:49 UTC

Evenimente importante

Week Ahead for FX, Bonds: U.S. Retail Sales, PMI Data Due as Focus Remains on Middle East

17 apr. 2026, 22:58 UTC

Câștiguri

Grupo Aeroportuario Del Pacifico: Announces Filing of 2025 Annual Report and Form 20-F

17 apr. 2026, 21:32 UTC

Market Talk

Cerebras IPO Adds to Big Year For AI Firms Going Public -- Market Talk

17 apr. 2026, 21:22 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

17 apr. 2026, 21:22 UTC

Market Talk

Moody's Downgrades Belgium to A1 -- Market Talk

17 apr. 2026, 20:52 UTC

Câștiguri

Schwab Investors Get Spooked by JPMorgan's AI Strategy. The Big Worry Is Cash Sweeps. -- Barrons.com

17 apr. 2026, 20:50 UTC

Market Talk
Câștiguri
Achiziții, Fuziuni, Preluări

Tech, Media & Telecom Roundup: Market Talk

17 apr. 2026, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

17 apr. 2026, 20:29 UTC

Câștiguri

These Stocks Are Today's Movers: Royal Caribbean, Dow Inc., Netflix, Intel, Albemarle, Autoliv, Alcoa, and More -- Barrons.com

17 apr. 2026, 20:11 UTC

Achiziții, Fuziuni, Preluări

UCB to Buy Neurona Therapeutics for Up to $1.15B

17 apr. 2026, 19:34 UTC

Market Talk
Câștiguri
Achiziții, Fuziuni, Preluări

Global Equities Roundup: Market Talk

17 apr. 2026, 19:34 UTC

Market Talk
Câștiguri
Achiziții, Fuziuni, Preluări

Analysts See Netflix's Deal Commentary as Notable -- Market Talk

17 apr. 2026, 19:31 UTC

Market Talk
Evenimente importante

Oil Futures Fall on Reopening of Strait of Hormuz -- Market Talk

17 apr. 2026, 19:26 UTC

Market Talk

U.S. Natural Gas Futures Edge Up -- Market Talk

17 apr. 2026, 19:21 UTC

Market Talk

Albemarle's Outperformance Belies Longer-Term Risks -- Market Talk

17 apr. 2026, 19:15 UTC

Market Talk

Danaher Seen Rebounding in 2H After Tools-Sector Weakness -- Market Talk

17 apr. 2026, 19:07 UTC

Market Talk

Danaher Faces Tough Comparative but Long‑Term Story Intact -- Market Talk

17 apr. 2026, 18:57 UTC

Evenimente importante

U.S. Stocks Surge on Hope Iran War Nearing End. Foreign Leaders Have a More Sober View. -- Barrons.com

17 apr. 2026, 18:53 UTC

Achiziții, Fuziuni, Preluări

UCB Expects 2026 Adjusted Ebitda Growth in High Single-Digit to Mid-Teens Percentage Range at Constant Exchange Rates

17 apr. 2026, 18:53 UTC

Achiziții, Fuziuni, Preluări

UCB 2026 Rev Guidance Unchanged

17 apr. 2026, 18:52 UTC

Achiziții, Fuziuni, Preluări

UCB: Neurona Deal to Include $650M Upfront and Up to $500M in Potential Future Milestones

17 apr. 2026, 18:52 UTC

Achiziții, Fuziuni, Preluări

UCB to Acquire Neurona Therapeutics for Up to $1.15B Including Potential Milestones

17 apr. 2026, 18:14 UTC

Market Talk
Evenimente importante

Precious Metals Close Higher as Stronger Demand Eyed -- Market Talk

17 apr. 2026, 18:00 UTC

Evenimente importante

Fed's Waller: Quick Resolution in Middle East Could Allow Cuts Later This Year

17 apr. 2026, 18:00 UTC

Evenimente importante

Fed's Waller: Job Losses May Not Signal Recession Amid Demographic Changes

17 apr. 2026, 17:31 UTC

Market Talk
Evenimente importante

U.S. Oil Rig Count Down By 1 at 410 -- Market Talk

17 apr. 2026, 17:26 UTC

Market Talk
Câștiguri

Netflix's Ability to Grow Engagement Seen as Up in the Air -- Market Talk

Comparație

Modificare preț

Inspire Medical Systems Inc Așteptări

Obiectiv de preț

By TipRanks

19.98% sus

Prognoză pe 12 luni

Medie 67.73 USD  19.98%

Maxim 85 USD

Minim 56 USD

În baza a 15 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruInspire Medical Systems Inc - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Cumpărare

15 ratings

4

Cumpărare

11

Păstrare

0

Vânzare

Sentiment

By Acuity

302 / 348 Clasament în Sănătate

Sentimentul știrilor

Evidențe de scădere

Volatilitate

Sub medie

Volumul știrilor (RCV)

Sub medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Inspire Medical Systems Inc

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.
help-icon Live chat